5.46 - 5.56
4.95 - 8.28
1.3K / 2.4K (Avg.)
-277.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.59%
Positive revenue growth while HUH1V.HE is negative. John Neff might see a notable competitive edge here.
179.92%
Gross profit growth above 1.5x HUH1V.HE's 1.93%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
42.16%
EBIT growth 1.25-1.5x HUH1V.HE's 29.02%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
42.16%
Operating income growth 1.25-1.5x HUH1V.HE's 29.02%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
-20.26%
Negative net income growth while HUH1V.HE stands at 84.67%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-21.30%
Negative EPS growth while HUH1V.HE is at 80.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-21.30%
Negative diluted EPS growth while HUH1V.HE is at 80.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.35%
Share count expansion well above HUH1V.HE's 0.40%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.35%
Diluted share count expanding well above HUH1V.HE's 0.40%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-157.58%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-329.13%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-26.92%
Negative 10Y revenue/share CAGR while HUH1V.HE stands at 8.08%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-26.92%
Negative 5Y CAGR while HUH1V.HE stands at 8.08%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-29.81%
Negative 3Y CAGR while HUH1V.HE stands at 20.98%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-146.57%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-146.57%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-152.08%
Negative 3Y OCF/share CAGR while HUH1V.HE stands at 159.10%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
119.59%
Net income/share CAGR above 1.5x HUH1V.HE's 28.13% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
119.59%
5Y net income/share CAGR above 1.5x HUH1V.HE's 28.13%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-15.03%
Negative 3Y CAGR while HUH1V.HE is 39.98%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-19.10%
Negative 3Y equity/share growth while HUH1V.HE is at 0.27%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.91%
AR growth well above HUH1V.HE's 23.82%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.35%
Inventory growth well above HUH1V.HE's 11.34%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.42%
Asset growth well under 50% of HUH1V.HE's 1.20%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-0.00%
We have a declining book value while HUH1V.HE shows 2.64%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
2.74%
We have some new debt while HUH1V.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
0.85%
We expand SG&A while HUH1V.HE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.